|
rdf:type |
|
|
lifeskim:mentions |
umls-concept:C0007113,
umls-concept:C0079419,
umls-concept:C0205179,
umls-concept:C0332293,
umls-concept:C0445204,
umls-concept:C0664336,
umls-concept:C0677043,
umls-concept:C0871261,
umls-concept:C1517927,
umls-concept:C1704632,
umls-concept:C1706817,
umls-concept:C2698872,
umls-concept:C2911692
|
|
pubmed:issue |
1
|
|
pubmed:dateCreated |
2007-11-16
|
|
pubmed:abstractText |
The ability to predict response to chemoradiotherapy before the treatment may allow protecting poorly responding patients from the side effects of neoadjuvant treatment. Several molecular markers have been proposed to radio and chemosensitivity of rectal cancer. In this study, from pre-irradiation tumor biopsies, a novel and promising candidate factor survivin, and p53 and Ki-67 were assessed as predictors of response to preoperative chemoradiotherapy.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Antimetabolites, Antineoplastic,
http://linkedlifedata.com/resource/pubmed/chemical/BIRC5 protein, human,
http://linkedlifedata.com/resource/pubmed/chemical/Fluorouracil,
http://linkedlifedata.com/resource/pubmed/chemical/Inhibitor of Apoptosis Proteins,
http://linkedlifedata.com/resource/pubmed/chemical/Ki-67 Antigen,
http://linkedlifedata.com/resource/pubmed/chemical/Microtubule-Associated Proteins,
http://linkedlifedata.com/resource/pubmed/chemical/Neoplasm Proteins,
http://linkedlifedata.com/resource/pubmed/chemical/TP53 protein, human,
http://linkedlifedata.com/resource/pubmed/chemical/Tumor Suppressor Protein p53
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jan
|
|
pubmed:issn |
0179-1958
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
23
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
37-45
|
|
pubmed:dateRevised |
2011-11-17
|
|
pubmed:meshHeading |
pubmed-meshheading:17805549-Adenocarcinoma,
pubmed-meshheading:17805549-Adult,
pubmed-meshheading:17805549-Aged,
pubmed-meshheading:17805549-Antimetabolites, Antineoplastic,
pubmed-meshheading:17805549-Chemotherapy, Adjuvant,
pubmed-meshheading:17805549-Digestive System Surgical Procedures,
pubmed-meshheading:17805549-Disease-Free Survival,
pubmed-meshheading:17805549-Female,
pubmed-meshheading:17805549-Fluorouracil,
pubmed-meshheading:17805549-Humans,
pubmed-meshheading:17805549-Immunohistochemistry,
pubmed-meshheading:17805549-Inhibitor of Apoptosis Proteins,
pubmed-meshheading:17805549-Ki-67 Antigen,
pubmed-meshheading:17805549-Male,
pubmed-meshheading:17805549-Microtubule-Associated Proteins,
pubmed-meshheading:17805549-Middle Aged,
pubmed-meshheading:17805549-Neoadjuvant Therapy,
pubmed-meshheading:17805549-Neoplasm Invasiveness,
pubmed-meshheading:17805549-Neoplasm Proteins,
pubmed-meshheading:17805549-Patient Selection,
pubmed-meshheading:17805549-Radiotherapy, Adjuvant,
pubmed-meshheading:17805549-Rectal Neoplasms,
pubmed-meshheading:17805549-Retrospective Studies,
pubmed-meshheading:17805549-Treatment Outcome,
pubmed-meshheading:17805549-Tumor Suppressor Protein p53
|
|
pubmed:year |
2008
|
|
pubmed:articleTitle |
Survivin, p53, and Ki-67 as predictors of histopathologic response in locally advanced rectal cancer treated with preoperative chemoradiotherapy.
|
|
pubmed:affiliation |
Department of Surgery, School of Medicine, Dokuz Eylul University, Izmir, Inciralti 35340, Turkey. cem.terzi@deu.edu.tr
|
|
pubmed:publicationType |
Journal Article
|
